Evidence map›Paper›PMID 27600663›Full record

ArticleScientific reports2016

A Molecularly Complete Planar Bacterial Outer Membrane Platform.

Chih-Yun Hsia, Linxiao Chen, Rohit R Singh, Matthew P DeLisa, Susan Daniel

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Spatially resolved charge-transfer kinetics at the quantum dot-microbe interface using fluorescence lifetime imaging microscopy.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Frontiers in microbiology · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Chih-Yun HsiaSchool of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, USA.
Linxiao ChenSchool of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, USA.
Rohit R SinghSchool of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, USA.
Matthew P DeLisaSchool of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, USA.
Susan DanielSchool of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, USA.
Cornell University · US

Funding

Engineered Outer Membrane Vesicles as DNA Vaccine Delivery VehiclesR21EB005669 · NIBIB · CORNELL UNIVERSITY · PI PUTNAM, DAVID A · 2006 to 2007
$398k
NIBIB NIH HHS R21 EB005669
6 · The paper itself

Abstract

The bacterial outer membrane (OM) is a barrier containing membrane proteins and liposaccharides that fulfill crucial functions for Gram-negative bacteria. With the advent of drug-resistant bacteria, it is necessary to understand the functional role of this membrane and its constituents to enable novel drug designs. Here we report a simple method to form an OM-like supported bilayer (OM-SB), which incorporates native lipids and membrane proteins of gram-negative bacteria from outer membrane vesicles (OMVs). We characterize the formation of OM-SBs using quartz crystal microbalance with dissipation (QCM-D) and fluorescence microscopy. We show that the orientation of proteins in the OM-SB matches the native bacterial membrane, preserving the characteristic asymmetry of these membranes. As a demonstration of the utility of the OM-SB platform, we quantitatively measure antibiotic interactions between OM-SBs and polymyxin B, a cationic peptide used to treat Gram-negative infections. This data enriches understanding of the antibacterial mechanism of polymyxin B, including disruption kinetics and changes in membrane mechanical properties. Combining OM-SBs with microfluidics will enable higher throughput screening of antibiotics. With a broader view, we envision that a molecularly complete membrane-scaffold could be useful for cell-free applications employing engineered membrane proteins in bacterial membranes for myriad technological purposes.

Indexed as

Bacterial Outer Membrane ProteinsKineticsLiposomesMicroscopy, FluorescenceQuartz Crystal Microbalance TechniquesBacterial Outer Membrane ProteinsLiposomes

Identifiers

PMID27600663
PMCPMC5013322
OpenAlexW2512130812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.